Back
Madrigal Pharmaceuticals Vs. Axsome Therapeutics Industry Stock Comparison
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
241.11
Seasonality Move:
23.49%
Sell
44
AXSM
Axsome Therapeutics
Last Price:
94.82
Seasonality Move:
24.95%
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $242.25. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $94.43. The Score for AXSM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $242.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight buying pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $94.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing slight buying pressure.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.59 | Sell |
| Relative Strength Index (14 RSI): | 47.77 | Sell |
| Chaikin Money Flow: | 54807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (236.7 - 253.26) | Sell |
| Bollinger Bands (100): | (227.09 - 277.47) | Sell |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.7 | Buy |
| Relative Strength Index (14 RSI): | 61.42 | Buy |
| Chaikin Money Flow: | 89031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.76 - 93.16) | Buy |
| Bollinger Bands (100): | (75.31 - 88.45) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 235.93 | Buy |
| 20-day SMA: | 242.86 | Sell |
| 50-day SMA: | 257.38 | Sell |
| 200-day SMA: | 242.76 | Sell |
| 8-day EMA: | 237.68 | Buy |
| 20-day EMA: | 242.21 | Buy |
| 50-day EMA: | 250.29 | Sell |
| 200-day EMA: | 239.85 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.3 | Buy |
| 20-day SMA: | 91.17 | Buy |
| 50-day SMA: | 87.58 | Buy |
| 200-day SMA: | 80.64 | Buy |
| 8-day EMA: | 92.46 | Buy |
| 20-day EMA: | 91.11 | Buy |
| 50-day EMA: | 87.67 | Buy |
| 200-day EMA: | 80.32 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.99 per share, a decrease this year of $1.26 per share, and an increase next year of $3.97 per share.
Madrigal Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||